{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:05:41Z","timestamp":1751256341703,"version":"3.41.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.revmed.2024.11.009","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:40:30Z","timestamp":1732538430000},"page":"408-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Entre le normal et le pathologique\u00a0: le concept de pr\u00e9-maladie appliqu\u00e9 aux pathologies auto-immunes syst\u00e9miques"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-694X","authenticated-orcid":false,"given":"L.","family":"Chiche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-E.","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Immediato Daien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.revmed.2024.11.009_bib0270","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19\u00a0CAR T-Cell therapy in autoimmune disease\u2014A case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"year":"2013","series-title":"Le normal et le pathologique","author":"Canguilhem","key":"10.1016\/j.revmed.2024.11.009_bib0275"},{"journal-title":"ACR Open Rheumatol","year":"2024","author":"Johnson","key":"10.1016\/j.revmed.2024.11.009_bib0280"},{"issue":"11","key":"10.1016\/j.revmed.2024.11.009_bib0285","doi-asserted-by":"crossref","first-page":"103184","DOI":"10.1016\/j.autrev.2022.103184","article-title":"Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: a systematic review and meta-analysis","volume":"21","author":"Dyball","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.revmed.2024.11.009_bib0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.revmed.2021.10.337","article-title":"Vers une meilleure stratification clinique dans les pathologies auto-immunes pour am\u00e9liorer la prise en charge du patient dans ses dimensions bio-psycho-sociales","volume":"43","author":"Escoda","year":"2022","journal-title":"Rev Med Interne"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0295","doi-asserted-by":"crossref","first-page":"103390","DOI":"10.1016\/j.autrev.2023.103390","article-title":"Complex relationships of type 2\u00a0and type 1\u00a0symptoms across various systemic autoimmune diseases","volume":"22","author":"Escoda","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0300","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-019-2013-9","article-title":"Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease","volume":"21","author":"Hafiz","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.revmed.2024.11.009_bib0305","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"16","key":"10.1016\/j.revmed.2024.11.009_bib0310","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"7776","key":"10.1016\/j.revmed.2024.11.009_bib0315","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1595-3","article-title":"Analysis of the B cell receptor repertoire in six immune-mediated diseases","volume":"574","author":"Bashford-Rogers","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.revmed.2024.11.009_bib0320","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard-2023-225349","article-title":"Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology","volume":"83","author":"Carter","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.revmed.2024.11.009_bib0325","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/0961203317692437","article-title":"The prevalence and determinants of anti-DFS70\u00a0autoantibodies in an international inception cohort of systemic lupus erythematosus patients","volume":"26","author":"Choi","year":"2017","journal-title":"Lupus"},{"issue":"8018","key":"10.1016\/j.revmed.2024.11.009_bib0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41586-024-07563-1","article-title":"Multiscale topology classifies cells in subcellular spatial transcriptomics","volume":"630","author":"Benjamin","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0335","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s13063-018-3076-7","article-title":"Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial","volume":"19","author":"Olsen","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.revmed.2024.11.009_bib0340","doi-asserted-by":"crossref","first-page":"886442","DOI":"10.3389\/fimmu.2022.886442","article-title":"Altered balance of pro-inflammatory immune cells to T regulatory cells differentiates symptomatic from asymptomatic individuals with anti-nuclear antibodies","volume":"13","author":"Gupta","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2024.11.009_bib0345","doi-asserted-by":"crossref","first-page":"866181","DOI":"10.3389\/fimmu.2022.866181","article-title":"Pre-clinical autoimmunity in lupus relatives: self-reported questionnaires and immune dysregulation distinguish relatives who develop incomplete or classified lupus from clinically unaffected relatives and unaffected, unrelated individuals","volume":"13","author":"Munroe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2024.11.009_bib0350","article-title":"Genetic analysis of asymptomatic antinuclear antibody production","author":"Hocaoglu","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.revmed.2024.11.009_bib0355","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/art.41414","article-title":"Interactions between genome-wide genetic factors and smoking influencing risk of systemic lupus erythematosus","volume":"72","author":"Cui","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.009_bib0360","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbi.2022.12.012","article-title":"The link between post-traumatic stress disorder and systemic lupus erythematosus","volume":"108","author":"Goldschen","year":"2023","journal-title":"Brain Behav Immun"},{"issue":"6315","key":"10.1016\/j.revmed.2024.11.009_bib0365","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.aah3580","article-title":"Social status alters immune regulation and response to infection in macaques","volume":"354","author":"Snyder-Mackler","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.revmed.2024.11.009_bib0370","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41584-024-01154-0","article-title":"Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis","volume":"20","author":"Holers","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0375","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","article-title":"Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis","volume":"11","author":"Tajik","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.revmed.2024.11.009_bib0380","doi-asserted-by":"crossref","first-page":"152143","DOI":"10.1016\/j.semarthrit.2022.152143","article-title":"Risk prediction models for incident systemic lupus erythematosus among women in the Nurses\u2019 health study cohorts using genetics, family history, and lifestyle and environmental factors","volume":"58","author":"Cui","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2024.11.009_bib0385","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.11.009_bib0390","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2024-eular.570","article-title":"Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial","author":"van Mulligen","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"10429","key":"10.1016\/j.revmed.2024.11.009_bib0395","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"issue":"10429","key":"10.1016\/j.revmed.2024.11.009_bib0400","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2024.11.009_bib0405","article-title":"Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease","author":"Deane","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"583","key":"10.1016\/j.revmed.2024.11.009_bib0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.revmed.2024.11.009_bib0415","doi-asserted-by":"crossref","first-page":"e004622","DOI":"10.1136\/rmdopen-2024-004622","article-title":"The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2\u00a0year data from the PRAIRI study","volume":"10","author":"Frazzei","year":"2024","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0420","doi-asserted-by":"crossref","first-page":"e001980","DOI":"10.1136\/rmdopen-2021-001980","article-title":"Passive smoking in childhood and adulthood and risk of rheumatoid arthritis in women: results from the French E3N cohort study","volume":"8","author":"Nguyen","year":"2022","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.revmed.2024.11.009_bib0425","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"10.1016\/j.revmed.2024.11.009_bib0430","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1016\/S2665-9913(23)00212-6","article-title":"Beyond very early systemic sclerosis: deciphering pre-scleroderma and its trajectories to open new avenues for preventive medicine","volume":"5","author":"Lescoat","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.revmed.2024.11.009_bib0435","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sj\u00f6gren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0440","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren's Syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.009_bib0445","doi-asserted-by":"crossref","first-page":"890522","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","article-title":"Differentiating between UCTD and early-stage SLE: from definitions to clinical approach","volume":"18","author":"Sciascia","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2024.11.009_bib0455","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.41935","article-title":"Association of a combination of healthy lifestyle behaviors with reduced risk of incident systemic lupus erythematosus","volume":"74","author":"Choi","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2024.11.009_bib0460","doi-asserted-by":"crossref","first-page":"21074","DOI":"10.1038\/srep21074","article-title":"Multisensory body representation in autoimmune diseases","volume":"6","author":"Finotti","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0465","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.revmed.2024.07.006","article-title":"French protocol for the diagnosis and management of systemic lupus erythematosus","volume":"45","author":"Amoura","year":"2024","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.revmed.2024.11.009_bib0470","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/art.39737","article-title":"Early, incomplete, or preclinical autoimmune systemic rheumatic diseases and pregnancy outcome","volume":"68","author":"Spinillo","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0475","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0961203318778368","article-title":"Less than 7hours of sleep per night is associated with transitioning to systemic lupus erythematosus","volume":"27","author":"Young","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2024.11.009_bib0480","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ebiom.2019.03.063","article-title":"Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients","volume":"42","author":"James","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.revmed.2024.11.009_bib0485","doi-asserted-by":"crossref","first-page":"e001980","DOI":"10.1136\/rmdopen-2021-001980","article-title":"Passive smoking in childhood and adulthood and risk of rheumatoid arthritis in women: results from the French E3N cohort study","volume":"8","author":"Nguyen","year":"2022","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.revmed.2024.11.009_bib0490","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.pec.2018.12.011","article-title":"Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: a randomized controlled trial","volume":"102","author":"Marshall","year":"2019","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.revmed.2024.11.009_bib0495","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12875-015-0272-3","article-title":"Psychological impact of lifestyle-related disease disclosure at general checkup: a prospective cohort study","volume":"16","author":"Tominaga","year":"2015","journal-title":"BMC Fam Pract"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0500","doi-asserted-by":"crossref","first-page":"e064552","DOI":"10.1136\/bmjopen-2022-064552","article-title":"Vagus nerve stimulation as a novel treatment for systemic lupus erythematous: study protocol for a randomised, parallel-group, sham-controlled investigator-initiated clinical trial, the SLE-VNS study","volume":"12","author":"Zinglersen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.revmed.2024.11.009_bib0505","doi-asserted-by":"crossref","first-page":"152558","DOI":"10.1016\/j.semarthrit.2024.152558","article-title":"The link between traumatic stress and autoimmune rheumatic diseases: a systematic scoping review","volume":"69","author":"Ploesser","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.revmed.2024.11.009_bib0510","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/rheumatology\/keq148","article-title":"Epstein-Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus","volume":"49","author":"Ulff-M\u00f8ller","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.revmed.2024.11.009_bib0515","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.42811","article-title":"Vitamin D and marine n-3\u00a0fatty acids for autoimmune disease prevention: outcomes two years after completion of a double-blind, placebo-controlled trial","volume":"76","author":"Costenbader","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"10.1016\/j.revmed.2024.11.009_bib0520","doi-asserted-by":"crossref","first-page":"e164141","DOI":"10.1172\/JCI164141","article-title":"Falling down the biological rabbit hole: Epstein-Barr virus, biography, and multiple sclerosis","volume":"132","author":"Horwitz","year":"2022","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.revmed.2024.11.009_bib0525","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41423-023-01051-8","article-title":"Immunoception: the insular cortex perspective","volume":"20","author":"Rolls","year":"2023","journal-title":"Cell Mol Immunol"},{"issue":"Suppl.\u00a01194","key":"10.1016\/j.revmed.2024.11.009_bib0265","first-page":"133","article-title":"A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems","volume":"37","author":"Romano","year":"2019","journal-title":"Clin Exp Rheumatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:35:58Z","timestamp":1751214958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324012827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0248866324012827"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.009","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entre le normal et le pathologique\u00a0: le concept de pr\u00e9-maladie appliqu\u00e9 aux pathologies auto-immunes syst\u00e9miques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}